Abstract

1 delta1‐trans‐tetrahydrocannabinol, (delta1‐THC) produces bronchodilatation in asthmatic patients. 2 Administered in 62 microliter metered volumes containing 50–200 microgram by inhalation from an aerosol device to patients judged to be in a steady state, it increased peak expiratory flow rate (PEFR) and forced expiratory volume in 1 second (FEV1). 3 The rate of onset, magnitude, and duration of the bronchodilator effect was dose related.

Number of times cited according to CrossRef: 20

  • , From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology, Physiological Reviews, 96, 4, (1593), (2016).
  • , Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity, Medical Hypotheses, 96, (35), (2016).
  • , The effect of cannabinoids on dinitrofluorobenzene-induced experimental asthma in mice, Respiratory Physiology & Neurobiology, 231, (7), (2016).
  • , Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …, Headache: The Journal of Head and Face Pain, 55, 6, (885-916), (2015).
  • , Cannabis smoking and respiratory health: Consideration of the literature, Respirology, 19, 5, (655-662), (2014).
  • , The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig, Pulmonary Pharmacology & Therapeutics, 26, 3, (373), (2013).
  • , Allergen Challenge Increases Anandamide in Bronchoalveolar Fluid of Patients With Allergic Asthma, Clinical Pharmacology & Therapeutics, 90, 3, (388-391), (2011).
  • , Cannabinoids as novel anti-inflammatory drugs, Future Medicinal Chemistry, 10.4155/fmc.09.93, 1, 7, (1333-1349), (2009).
  • , Cannabinoids, Neurobiology of Addiction, 10.1016/B978-012419239-3/50044-8, (289-337), (2006).
  • , Evaluation of a vaporizing device (Volcano®) for the pulmonary administration of tetrahydrocannabinol, Journal of Pharmaceutical Sciences, 95, 6, (1308-1317), (2006).
  • , Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?, Journal of Neuroimmunology, 166, 1-2, (3), (2005).
  • , Clinical Pharmacodynamics of Cannabinoids, Journal of Cannabis Therapeutics, 10.1300/J175v04n01_03, 4, 1, (29-78), (2004).
  • , Pharmacokinetics and Pharmacodynamics of Cannabinoids, Clinical Pharmacokinetics, 10.2165/00003088-200342040-00003, 42, 4, (327-360), (2003).
  • , Airway effects of marijuana, cocaine, and other inhaled illicit agents, Current Opinion in Pulmonary Medicine, 7, 2, (43), (2001).
  • , Pharmacological evaluation of aerosolized cannabinoids in mice, European Journal of Pharmacology, 399, 2-3, (141), (2000).
  • , Characterization of the effects of cannabinoids on guinea‐pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves, British Journal of Pharmacology, 130, 7, (1720-1726), (2009).
  • , Alternative medicine for allergy and asthma, Journal of Allergy and Clinical Immunology, 106, 4, (603), (2000).
  • , Microsomal cytochrome P450-mediated liver and brain anandamide metabolism, Biochemical Pharmacology, 50, 5, (677), (1995).
  • , 5 Towards cannabinoid drugs, , 10.1016/S0079-6468(08)70422-3, (159-207), (1987).
  • , Current Status of Therapeutic Opportunities Based on Cannabinoid Research. An Overview, The Journal of Clinical Pharmacology, 21, S1, (2S-7S), (2013).